2015-01-01
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide
Publication
Publication
Journal of Clinical Endocrinology and Metabolism
,
Volume 100
-
Issue 4
p. 1689-
1698
Copyright
| Additional Metadata | |
|---|---|
| Persistent URL | dx.doi.org/10.1210/jc.2014-4350, hdl.handle.net/1765/82650 |
| Journal | Journal of Clinical Endocrinology and Metabolism |
| Citation |
Bengtsson, D, Schrøder, H.D, Andersen, M, Maiter, D, Berinder, K, Rasmussen, U.F, … Burman, P. (2015). Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide. Journal of Clinical Endocrinology and Metabolism, 100(4), 1689–1698. doi:10.1210/jc.2014-4350
|